Significance of Inulin Fructans in the Human Diet
Corresponding Author
Gertjan Schaafsma
Advisory Services in Food, Health and Safety, Rembrandtlaan 12, 3925 VD, Scherpenzeel, The Netherlands
Direct inquiries to author Schaafsma (E-mail: [email protected]).Search for more papers by this authorJoanne L. Slavin
Dept. of Food Science and Nutrition, Univ. of Minnesota, 1334 Eckles Avenue, St. Paul, MN, 55108 U.S.A
Search for more papers by this authorCorresponding Author
Gertjan Schaafsma
Advisory Services in Food, Health and Safety, Rembrandtlaan 12, 3925 VD, Scherpenzeel, The Netherlands
Direct inquiries to author Schaafsma (E-mail: [email protected]).Search for more papers by this authorJoanne L. Slavin
Dept. of Food Science and Nutrition, Univ. of Minnesota, 1334 Eckles Avenue, St. Paul, MN, 55108 U.S.A
Search for more papers by this authorAbstract
This paper reviews the physicochemical properties and nutritional significance of inulin fructans (oligofructose and inulin). These compounds are naturally present in a large number of food crops and serve in our diet as dietary fiber. Inulin fructans can be isolated and purified from the chicory root and used as ingredients in a large range of foods to improve structure and/or taste and to increase the intake of dietary fiber. Inulin fructans have a low caloric value, are safe, and generally well tolerated up to a level of 20 g/d. They exert a range of effects, which can be differentiated into direct effects on the gut and the intestinal flora and indirect systemic effects. Direct effects on the gut include prebiotic (bifidogenic) effects, improvement of bowel habits and bowel function in constipated subjects, increased colonic absorption of minerals (Ca and Mg), and secretion of satiety hormones. Indirect effects are on blood lipids, bone mineral content, the immune system, and energy homeostasis. These issues are discussed and it is argued that promising avenues for research are particularly in the areas of energy homeostasis and systemic low-grade inflammation in relation to changes in the composition of the intestinal microbiota.
References
- Abrams SA, Griffin IJ, Hawthorne KM, Chen Z, Gunn SK, Wilde M, Darlington G, Shypailo RJ, Ellis KJ. 2005a. Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res 20: 945–53.
- Abrams SA, Griffin IJ, Hawthorne K, Liang L, Gunn S, Darlington G, Ellis K. 2005b. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr 82: 471–6.
- Abrams SA, Griffin IJ, Hawthorne KM, Ellis KJ. 2007. Effect of prebiotic supplementation and calcium intake on body mass index. J Pediatr 151: 293–8.
- Alles MS, De Roos NM, Bakx JC, van de Lisdonk E, Zock PL, Hautvast JGAJ. 1999. Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr 69: 64–9.
- Anastasovska J, Arora T, Sanchez Canon GJ, Parkinson JR, Touhy K, Gibson GR, Nadkarni NA, So PW, Goldstone AP, Thomas EL, Hankir MK, van Loo J, Modi N, Bell JD, Frost G. 2012. Fermentable carbohydrate alters hypothalamic neuronal activity and protects against the obesogenic environment. Obesity (Silver Spring) 20: 1016–23.
- Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. 2008. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 138: 1091–95.
- Bailey JS, Blankenship LC, Cox NA. 1991. Effect of fructooligosaccharide on Salmonella colonization of the chicken intestine. Poultry Sci 70: 2433–38.
- Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, Flint HJ. 2006. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72: 3593–99.
- Benjamin JL, Hedin CRH, Koutsoumpas A, Ng SC, McCarthy NE, Hart AL, Kamm MA, Sanderson JD, Knight SC, Forbes A, Stagg AJ, Whelan K, Lindsay JO. 2011. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut 60: 923–30.
- Beylot M. 2005. Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr 93: S163–8.
- Boeckner LS, Schnepf MI, Tungland BC. 2001. Inulin: a review of nutritional and health implications. Adv Food Nutr Res 43: 1–63.
- Bonnema AG, Kolberg LW, Thomas W, Slavin JL. 2010. Gastrointestinal tolerance of chicory inulin products. J Am Diet Assoc 110: 865–8.
- Bornet FRJ, Brouns F. 2002. Immune-stimulating and gut health-promoting properties of short-chain fructo-oligosaccharides. Nutr Rev 60: 326–34.
- Bouhnik Y, Flourié B, Andrieux C, Bisetti N, Briet F, Rambaud JC. 1996. Effects of Bifidobacterium sp fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans. Eur J Clin Nutr 50: 269–73.
- Bovee-Oudenhoven IMJ, ten Bruggencate SJM, Lettink-Wissink MLG, van der Meer R. 2003. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats. Gut 52: 1572–78.
- Canani RB, Di Costanzo M, Leone L, Pedata M, Meli R, Calignano A. 2011. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17: 1519–28.
- Canani RB, Di Costanzo M, Leone L. 2012. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics 4: 4–7.
- Cani PD, Joly E, Horsmans Y, Delzenne NM. 2006. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 60: 567–72.
- Cani PD, Possemiers S, van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091–103.
- Casellas F, Borruel N, Torrejon A, Varela E, Antolin M, Guarner F, Malagelada J-R. 2007. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 25: 1061–7.
- Catala I, Butel MJ, Bensaada M, Popot F, Tessedre AC, Rimbault A, Szylit O. 1999. Oligofructose contributes to the protective role of bifidobacteria in experimental necrotising enterocolitis in quails. J Med Microbiol 48: 89–94.
- Causey JL, Feirtag JM, Gallaher DD, Tungland BC, Slavin JL. 2000. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutr Res 20: 191–201.
- Cherbut C, Michel C, Lecannu G. 2003. The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr 133: 21–7.
- Clausen MR, Jorgensen J, Mortensen PB. 1998. Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate. Dig Dis Sci 43: 2696–707.
- Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148: 1258–70.
- Conterno L, Fava F, Viola R, Tuohy KM. 2011. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr 6: 241–60.
- Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CG. 2007. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA 104: 7617–21.
- Coudray C, Bellanger J, Castiglia-Delavaud C, Remesy C, Vermorel M, Rayssignuier Y. 1997. Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men. Eur J Clin Nutr 51: 375–80.
- Coussement PAA. 1999. Inulin and oligofructose: safe intakes and legal status. J Nutr 129: 1412S–7.
- Cummings JH, Macfarlane GT. 1997. Role of intestinal bacteria in nutrient metabolism. Clin Nutr 16: 3–11.
- Dahl WJ, Wright AR, Specht GJ, Christman M, Mathews A, Meyer D, Boileau T, Willis HJ, Langkamp-Henken B. 2014. Consuming foods with added oligofructose improves stool frequency: a randomised trial in healthy young adults. J Nutr Sci 3: e7; doi:10.1017/jns.2014.6.
- Delzenne NM, Kok NN. 1999. Biochemical basis of oligofructose-induced hypolipidemia in animal models. J Nutr 129: 1467S–70.
- Delzenne NM, Cani PD, Daubioul C, Neyrinck AM. 2005. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 93: S157–61.
- Den Hond E, Geypens B, Ghoos Y. 2000. Effect of high performance chicory inulin on constipation. Nutr Res 20: 731–6.
- De Preter V, Vanhoute T, Huys G, Swings J, Rurtgeerts P, Verbeke K. 2008. Baseline microbiota activity and initial bifidobacteria counts influence responses to prebiotic dosing in healthy subjects. Aliment Pharmacol Ther 27: 504–13.
- Dong P, Yang Y, Wang WP. 2010. The role of intestinal bifidobacteria on immune system development in young rats. Early Hum Dev 86: 51–8.
- Doran AL, Verran J. 2007. A clinical study on the effect of the prebiotic inulin in the control of oral malodour. Microb Ecol Health Dis 19: 158–63.
- Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS, Flint HJ. 2004. Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 91: 915–23.
- European Commission. 2008. Commission Directive 2008/100/EC of 28 October 2008 amending Council Directive 90/496/EEC on nutrition labeling for foodstuffs as regards recommended daily allowances, energy conversion factors and definitions.
- European Food Safety Authority. 2010. Scientific opinion on dietary reference values for carbohydrates and dietary fibre. EFSA J 8: 1464, 1–17.
- European Food Safety Authority. 2014. Scientific Opinion on the substantiation of a health claim related to nondigestible carbohydrates and a reduction of post-prandial glycaemic responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA J 12: 3513, 1–13.
- FAO. 1998. Carbohydrates in human nutrition. Report of a joint FAO/WHO Expert Consultation. FAO Food Nutr Paper 66: 1–140.
- Food and Drug Administration. 2014. Food labeling: revision of the nutrition and supplement facts labels. Available from: https://www.federalregister.gov/articles/2014/03/03/2014--04387/food-labeling-revision-of-the-nutrition-and-supplement-facts-labels#h-50. Accessed 2014 June 3.
- Fooks LJ, Gibson GR. 2002. In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiol Ecol 39: 67–75.
- Franck A. 2002. Technological functionality of inulin and oligofructose. Br J Nutr 87: S287–91.
- Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H. 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469: 543–7.
- Fuller R, Gibson GR. 1997. Modification of the intestinal microflora using probiotics and prebiotics. Scand J Gastroenterol 222: 28–31.
- Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58: 1509–17.
- Gibson GR, Wang X. 1994a. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 118: 121–8.
- Gibson GR, Wang X. 1994b. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77: 412–20.
- Gibson G, Beatty E, Wang X, Cummings J. 1995. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterol 108: 975–82.
- Glibowski P, Bukowska A. 2011. The effect of pH, temperature and heating time on inulin chemical stability. Acta Sci Pol Technol Aliment 10: 189–96.
- Griffin IJ, Davila PM, Abrams SA. 2002. Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br J Nutr 87: S187–91.
- Hartemink R, Quataert MCJ, Van Laere KMJ, Nout M, Rombouts F. 1995. Degradation and fermentation of fructo – oligosaccharides by oral streptococci. J Appl Bacteriol 79: 551–7.
- Havenaar R. 2000. Scientific evidence for beneficial effects of inulin DP9 on the intestinal flora of humans. Zeist, The Netherlands: TNO Nutrition and Food Research. Report no. V2537.
- Havenaar R, Petitet S. 1996. Inulin: a literature review on fermentation and microbial ecology in the intestinal tract with specific emphasis on the stimulation of Bifidobacterium. Zeist, The Netherlands: TNO Nutrition and Food Research. Report no. V96–438E.
- Health Canada. 2012. Policy for labeling and advertising of dietary fibre- containing food products. Available from: http://www.hc-sc.gc.ca/fn-an/legislation/pol/fibre-label-etiquetage-eng.php. Accessed 2014 June 3.
- Health Council of The Netherlands. 2006. Guideline for dietary fiber intake. The Hague: Health Council of The Netherlands. Report no. 2006/03.
- Holscher HD, Doligale JL, Bauer LL, Gourineni V, Pelkman CL, Fahey GC, Swanson KS. 2014. Gastrointestinal tolerance and utilization of agave inulin by healthy adults. Food Funct 5: 1142–9.
- Hsu CK, Liao JW, Chung YC, Hsieh CP, Chan YC. 2004. Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. J Nutr 134: 1523–8.
- Hunter JO, Tuffnell Q, Lee AJ. 1999. Controlled trial of oligofructose in the management of irritable bowel syndrome. J Nutr 129: 1451S–3.
- Institute of Medicine of the National Academies. 2001. Dietary reference intakes for energy carbohydrate, fiber, fatty acids, cholesterol, protein, and amino acids. Washington DC: The Natl. Academy Press.
- Johnson AM, Olefsky JM. 2013. The origins and drivers of insulin resistance. Cell 152: 673–84.
- Karalus M, Clark M, Greaves KA, Thomas W, Vickers Z, Kuyama M, Slavin J. 2012. Fermentable fibers do not affect satiety or food intake by women who do not practice restrained eating. J Acad Nutr Diet 112: 1356–62.
- Kerckhoffs APM, Samsom M, Van Der Rest ME, De Vogel J, Knol J, Ben-Amor K, Akkermans LMA. 2009. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 15: 2887–92.
- Kim YY, Jang KH, Lee EY, Cho YH, Kang SA, Ha WK, Choue RW. 2004. The effect of chicory fructan fiber on calcium absorption and bone metabolism in Korean postmenopausal women. Nutr Sci 7: 151–7.
- Kleessen B, Sykura B, Zunft HJ, Blaut M. 1997. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 65: 1397–402.
- Koleva PT, Valcheva RS, Sun X, Gänzle MG, Dieleman LA. 2012. Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats. Br J Nutr 108: 1633–43.
- Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, Kamm MA, Knight SC, Forbes A. 2006. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 55: 348–55.
- Lopez P, Gonzalez-Rodriguez I, Gueimonde M, Margolles A, Suarez A. 2011. Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity. PLoS One 6: e24776.
- Louis P, Young P, Holtrop G, Flint HJ. 2010. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA: acetate CoA-transferase gene. Environ Microbiol 12: 304–14.
- Macfarlane GT, Macfarlane S. 1997. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol 222: 3–9.
- Macfarlane GT, Macfarlane S. 2011. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 45: S120–7.
- Marteau P, Flourié B. 2001. Tolerance to low-digestible carbohydrates: symptomatology and methods. Br J Nutr 85: S17–21.
- Marteau P, Jacobs H, Cazaubiel M, Signoret C, Prevel JM, Housez B. 2010. Effects of chicory inulin in constipated elderly people: a double-blind controlled trial. Intl J Food Sci Nutr 62: 164–70.
- Martin BR, Braun MM, Wigertz K, Bryant R, Zhao Y, Lee W, Kempa-Steczko A, Weaver CM. 2010. Fructo-oligosaccharides and calcium absorption and retention in adolescent girls. J Am Coll Nutr 29: 382–86.
- Menard O, Butel MJ, Gaboriau-Routhiau V, Waligora-Dupriet AJ. 2008. Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 74: 660–6.
- Meyer D, Stasse-Wolthuis M. 2009. The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr 63: 1277–89.
- Mitsuoka T. 1990. Bifidobacteria and their role in human health. J Ind Microbiol 6: 263–8.
- Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. 2006. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 91: 814–9.
- Morrison D, Mackay W, Edwards C, Preston T, Dodson B, Weaver L. 2006. Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? Br J Nutr 96: 570–7.
- Moshfegh AJ, Friday JE, Goldman JP, Ahuja JKC. 1999. Presence of inulin and oligofructose in the diets of Americans. J Nutr 129: 1407S–11.
- Ng SC, Benjamin JL, McCarthy NE, Hedin CR, Koutsoumpas A, Plamondon S, Price CL, Hart AL, Kamm MA, Forbes A, Knight SC, Lindsay JO, Whelan K, Stagg AJ. 2011. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis 17: 2027–37.
- Niness KR. 1999. Inulin and oligofructose: what are they? J Nutr 129: 1402S–6.
- Olesen M, Gudmand-Høyer E. 2000. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr 72: 1570–5.
- Paineau D, Payen F, Panserieu S, Coulombier G, Sobaszek A, Lartigau I, Brabet M, Galmiche J, Tripodi D, Sacher-Huvelin S, Chapalain V, Zourabichvili O, Respondek F, Wagner A, Bornet FRJ. 2008. The effects of regular consumption of short-chain fructo- oligosaccharides on digestive comfort of subjects with minor functional bowel disorders. Br J Nutr 99: 311–8.
- Parnell JA, Reimer RA. 2009. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89: 1751–9.
- Pedersen A, Sandström B, van Amelsvoort JMM. 1997. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr 78: 215–22.
- Peters HPF, Boers HM, Haddeman E, Melnikov SM, Qvyjt F. 2009. No effect of added beta-glucan or of fructooligosaccharide on appetite or energy intake. Am J Clin Nutr 89: 58–63.
- Pierre F, Perrin P, Champ M, Bornet F, Meflah K, Menanteau J. 1997. Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res 57: 225–8.
- Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs H, van Loo J, Watzl B, Collins JK. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85: 488–96.
- Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. 2009. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101: 541–50.
- Reddy BS, Hamid R, Rao CV. 1997. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18: 1371–4.
- Rijkers GT, Mulder L, Rombouts FM, Akkermans 2012. Gut microbiota in health and disease: a personalized summary of the third workshop. (13–15 September 2012, Maastricht, the Netherlands). Available from: www.gutmicrobiota.org. Accessed 2014 June 3.
- Roberfroid M. 1993. Dietary fiber, inulin, and oligofructose: a review comparing their physiological effects. Crit Rev Food Sci Nutr 33: 103–48.
- Roberfroid MB. 1999. Caloric value of inulin and oligofructose. J Nutr 129: 1436S–7.
- Roberfroid M. 2007. Prebiotics: the concept revisited. J Nutr 137: 830S–7.
- Roberfroid MB, van Loo J, Gibson GR. 1998. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128: 11–9.
- Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Leotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck, AM, Meheust A. 2010. Prebiotic effects: metabolic and health benefits. Br J Nutr 104: S1–63.
- Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T, Martí-Romero M, Lopez RM, Florido J, Campoy C. 2010. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 104: 83–92.
- Scholtens PAMJ, Alles MS, Willemsen LEM, van den Braak C, Bindels JG, Boehm G, Govers MJAP. 2006. Dietary fructo-oligosaccharides in healthy adults do not negatively affect faecal cytotoxicity: a randomised, double-blind, placebo-controlled crossover trial. Br J Nutr 95: 1143–9.
- Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, Asil Y, Glueer CC, Schrezenmeir J. 2007. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr 137: 838S–46.
- Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Wolf BW, Chow JM, Garleb KA, Williams JA, Fahey GC. 2002. J Nutr 132: 3042–50.
- Tahiri M, Tressol JC, Arnaud J, Bornet F, Bouteloup-Demange C, Feillet-Coudray C, Ducros V, Pepin D, Brouns F, Rayssiguier AM, Coudray C. 2001. Five-week intake of short-chain fructo-oligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. J Bone Miner Res 16: 2152–60.
- Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, van der Meer R. 2003. Dietary fructo-oligosaccharides dose-dependently increase translocation of salmonella in rats. J Nutr 133: 2313–8.
- Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Katan MB, van der Meer R. 2004. Dietary fructo-oligosaccharides and inulin decrease resistance of rats to salmonella: protective role of calcium. Gut 53: 530–5.
- Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Katan MB, van der Meer R. 2006. Dietary fructooligosaccharides affect intestinal barrier function in healthy men. J Nutr 136: 70–4.
- Tominaga S, Hirayama M, Adachi T, Tokunaga T, Iino H. 1999. Effects of ingested fructooligosaccharides on stool frequency in healthy female volunteers: a placebo-controlled study. Biosci Microflora 18: 49–53.
- Tomono Y, Yamamoto T, Yamaguchi H. 2010. Effect of synthesized inulin on bowel habit and fecal microflora in healthy adults with low fecal frequency. Jpn Pharmacol Ther 38: 1031–40.
- Tremaroli V, Bäckhed F. 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489: 242–9.
- Tuohy KM, Kolida S, Lustenberger AM, Gibson GR. 2001a. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides—a human volunteer study. Br J Nutr 86: 341–8.
- Tuohy KM, Finlay RK, Wynne AG, Gibson GR. 2001b. A human volunteer study on the prebiotic effects of HP-inulin—faecal bacteria enumerated using fluorescent In situ hybridisation (FISH). Anaerobe 7: 113–8.
- van den Heuvel EGHM, Weidauer T. 1999. Role of the non-digestible carbohydrate lactulose in the absorption of calcium. Med Sci Monit 5: 1231–7.
- van den Heuvel EGHM, Schaafsma G, Muys T, Van Dokkum W. 1998. Nondigestible oligosaccharides do not interfere with calcium and nonheme-iron absorption in young, healthy men. Am J Clin Nutr 67: 445–51.
- van den Heuvel EGHM, Muijs T, Van Dokkum W, Schaafsma G. 1999a. Lactulose stimulates calcium absorption in postmenopausal women. J Bone Miner Res 14: 1211–6.
- van den Heuvel EGHM, Muys T, Van Dokkum W, Schaafsma G. 1999b. Oligofructose stimulates calcium absorption in adolescents. Am J Clin Nutr 69: 544–8.
- van den Heuvel EGHM, Schoterman MHC, Muijs T. 2000. Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. J Nutr 130: 2938–42.
- van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel EGHM. 1999. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 53: 1–7.
- van Loo J, Coussement P, De Leenheer L, Hoebregs H, Smits G. 1995. On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr 35: 525–52.
- van Loo J, Cummings J, Delzenne N, Englyst H, Franck A, Hopkins M, Kok N, Macfarlane G, Newton D, Quigley M, Roberfroid M, van Vliet T, van den Heuvel EGHM. 1999. Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94–1095). Br J Nutr 81: 121–32.
- van Nuenen MHMC, Meyer PD, Venema K. 2003. The effect of various inulins and Clostridium difficile on the metabolic activity of the human colonic microbiota in vitro. Microb Ecol Health Dis 15: 137–44.
- Ventura M, Turroni F, Bottacini F, Guebellini V, Van Sinderen D. 2010. Bifidobacterial ecology and comparative genomics, perspectives and prospects. In: B Mayo, D Van Sinderen, editors. Bifidobacteria genomics and molecular aspects. Caister Academic Press, Norfolk, UK. p 31–44.
- Verhoef SPM, Meyer D, Westerterp KR. 2011. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3–36 concentrations and energy intake. Br J Nutr 106: 1757–62.
- Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. 2011. Regulation of inflammation by short chain fatty acids. Nutrients 3: 858–76.
- Vogt L, Ramasamy U, Meyer D, Pullens G, Venema K, Faas MM, Schols HA, de Vos P. 2013. Immune modulation by different types of ß2 -> 1-fructans is toll-like receptor-dependent. PLoS One 8: e68367.
- Vogt LM, Meyer D, Pullens G, Faas MM, Venema K, Ramasamy U, Schols HA, de Vos P. 2014. Toll-like receptor 2 activation by β1->2-fructans protects barrier function of T84 human intestinal epithelial cells in a chain length-dependent manner. J Nutr 144:1002–8.
- Wang X, Gibson GR. 1993. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 75: 373–80.
- Welters C, Heineman E, Thunnissen F, van den Bogaard A, Soeters P, Baeten C. 2002. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum 45: 621–7.
- Williams CM, Jackson KG. 2002. Inulin and oligofructose: effects on lipid metabolism from human studies nutritional and health benefits of inulin and oligofructose. Br J Nutr 87: S261–4.
- Winkler J, Butler R, Symonds E. 2007. Fructo-oligosaccharide reduces inflammation in a dextran sodium sulphate mouse model of colitis. Dig Dis Sci 52: 52–8.